Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Votre recherche
Pays: Germany,Macedonia, the former Yugoslav Republic of,Serbia,South Africa,United Kingdom,Czech Republic,Italy,Poland,Spain - Le promoteur: Professor
Professor
MAJ Il y a 5 ans
A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia
This study consists of a 4 week run-in period with a Ca based phosphate binder and 12 weeks treatment period by MCI-196 or placebo, (both on Ca based phosphate binder). During the treatment period, MCI-196 or placebo will be titrated every 3 weeks.
Pays
Czech Republic
,
France
,
Germany
,
Italy
,
Macedonia, the former Yugoslav Republic of
,
Poland
,
Serbia
,
South Africa
,
Spain
,
United Kingdom
,
Organes
Aucun
Spécialités
Aucun
Essai clos aux inclusions
Plus d'informations
1